News for 'RNA'

Air pollution may hinder India's fight against COVID-19: Scientists

Air pollution may hinder India's fight against COVID-19: Scientists

Rediff.com27 Oct 2020

Long-term exposure to chronically high PM2.5 levels weakens the ability of the lungs to fend off infections, therefore making people more susceptible to COVID-19, the scientists said.

It's true! Fathers who exercise have fitter babies

It's true! Fathers who exercise have fitter babies

Rediff.com3 Nov 2018

When fathers exercise, children are healthier, finds a study!

Govt mulls 'Mission COVID Suraksha' with Rs 3,000 cr corpus

Govt mulls 'Mission COVID Suraksha' with Rs 3,000 cr corpus

Rediff.com25 Aug 2020

The aim of the mission is to accelerate the development of at least six vaccine candidates and ensure that they are licenced and introduced in market for emergency use at the earliest.

With 2.4 lakh tests, India still has a long way to go

With 2.4 lakh tests, India still has a long way to go

Rediff.com16 Apr 2020

Experts feel the figures are modest for a count of the size of 1.3 billion and "much more number of tests" are needed to combat COVID-19 outbreak in the country.

Pfizer says its Covid vaccine is 95% effective in final trials

Pfizer says its Covid vaccine is 95% effective in final trials

Rediff.com18 Nov 2020

Pfizer and BioNTech said they have concluded phase 3 study of their mRNA-based COVID-19 vaccine candidate BNT162b2, meeting all primary efficacy endpoints.

'Everyone had spelt doomsday for India, but that did not happen'

'Everyone had spelt doomsday for India, but that did not happen'

Rediff.com23 May 2020

'People had said it will explode and everyone will die. Nothing of that sort has happened.' 'Our government has done a splendid job so far.'

'We will price Covid vaccine below Rs 1,000'

'We will price Covid vaccine below Rs 1,000'

Rediff.com29 Jul 2020

Pune's Serum Institute of India, the world's largest vaccine maker by volume, is placing its bets on the Oxford-AstraZeneca vaccine candidate AZD1222 with CEO Adar Poonawalla stating he would start manufacturing at personal risk.

UK signs deal for 90 million COVID-19 vaccine doses

UK signs deal for 90 million COVID-19 vaccine doses

Rediff.com20 Jul 2020

To enable large-scale vaccine studies to take place across the UK, the aim is to get 500,000 people signed up by October, which is considered vital in the fight against coronavirus.

ICMR revises advisory on use of hydroxychloroquine

ICMR revises advisory on use of hydroxychloroquine

Rediff.com23 May 2020

Three new categories -- all asymptomatic healthcare workers working in non-COVID hospitals/areas of COVID hospitals/blocks, asymptomatic frontline workers such as surveillance workers deployed in containment zones and paramilitary/police personnel involved in COVID-19 related activities -- have now been included.

India blundered along, exactly as every other country did

India blundered along, exactly as every other country did

Rediff.com23 Jun 2021

Not to say that India couldn't have handled the situation better, but on average, it didn't do anywhere near as badly as the naysayers make it out argues Rajeev Srinivasan.

What made TnQ hit the headlines

What made TnQ hit the headlines

Rediff.com19 Sep 2008

In an exclusive interview to rediff.com, TnQ Books and Journals Manging Director Mariam Ram speaks about the growth of TnQ.

All you need to know about COVID-19 testing

All you need to know about COVID-19 testing

Rediff.com14 Apr 2020

Two kinds of diagnostic tests are being currently used in India -- RT-PCR test and rapid antibodies test -- as per the global health norms.

90-year-old Maggie world's first to get anti-COVID jab

90-year-old Maggie world's first to get anti-COVID jab

Rediff.com8 Dec 2020

Maggie is among the first set of people contacted in advance by the NHS for the jab based on a pre-determined health risk criteria and will include 87-year-old British Indian grandfather of nine Hari Shukla, who will get his first dose at a hospital in Newcastle.

Hope for pain-free cancer cure

Hope for pain-free cancer cure

Rediff.com12 Apr 2007

A revolutionary new study may boost the effectiveness of chemotherapy drugs and significantly curb the usual, horrible side effects.

COVID-19 vaccine development at early stage in India: Experts

COVID-19 vaccine development at early stage in India: Experts

Rediff.com23 May 2020

The Indian government and private firms have stepped up efforts to develop a vaccine to halt the spread of COVID-19 which has claimed over 3,700 lives with more than 1,25,000 cases in the country.

India readies for massive testing exercise after lockdown

India readies for massive testing exercise after lockdown

Rediff.com28 Mar 2020

The ICMR is working on a war footing to develop the testing ecosystem -- especially for the screening blood tests. NIV, Pune, is in the process of validating antibody-based screening kits.

Why Bihar is conducting so few Covid-19 tests

Why Bihar is conducting so few Covid-19 tests

Rediff.com3 Jul 2020

What worries health experts is that Bihar's testing rate per million is less than one-third of the national average of 6,622 tests per million, reports M I Khan.

Received Both Doses? Be Careful Please

Received Both Doses? Be Careful Please

Rediff.com23 Jul 2021

'You will still want to take all the necessary precautions, which is the right thing to do.'

Swedish footballer red-carded for farting during match

Swedish footballer red-carded for farting during match

Rediff.com23 Jun 2016

A Swedish footballer has hit out after being sent off for breaking wind during a match.

'Covid-free' Trump offers to 'kiss everyone' at rally

'Covid-free' Trump offers to 'kiss everyone' at rally

Rediff.com13 Oct 2020

Prior to his speech Trump tossed masks into the crowd.

Lockdown tamed doubling rate of COVID-19 cases: Health ministry

Lockdown tamed doubling rate of COVID-19 cases: Health ministry

Rediff.com17 Apr 2020

Joint Secretary in the Health Ministry Lav Agarwal claimed that India has been doing better than many other countries on the outcome ratio, which is the number of recoveries from coronavirus infection versus the number of deaths.

A mask that can deactivate COVID-19

A mask that can deactivate COVID-19

Rediff.com8 Jul 2020

'If people use the mask properly, we can confidently say that this is as protective as the best mask in the market.'<

Indian-American gets $1.4 million grant for stem cell research

Indian-American gets $1.4 million grant for stem cell research

Rediff.com2 Sep 2014

Dr Prashanth Rangan was among the 22 outstanding early-career researchers who were named Pew Scholars in the Biomedical Sciences. Rediff.com's George Joseph reports

Ranbaxy unveils anti-retroviral pill

Ranbaxy unveils anti-retroviral pill

Rediff.com4 Feb 2003

Ranbaxy Laboratories Ltd launched an anti-retroviral product, ABACAVIR, in India. The product, bioequivalent to the innovator brand, will be marketed in India under the brand name VIROL as 300 mg tablet formulation.

Continue military aid, Nepal urges India

Continue military aid, Nepal urges India

Rediff.com8 Feb 2005

The request was conveyed by Chief of the Royal Nepalese Army (RNA) Gen. Pyar Jung Thapa to the Indian Ambassador to Nepal Shiv Shanker Mukherjee.

'COVID-19 vaccine will be made in India'

'COVID-19 vaccine will be made in India'

Rediff.com12 Jun 2020

'I can say with confidence that any future SARS-CoV-2 vaccine, developed anywhere in the world, would have to be manufactured in India, if it is to be affordable and of high quality.'

How we can DEFEAT Covid in 6 months!

How we can DEFEAT Covid in 6 months!

Rediff.com30 Mar 2021

'If we wear a mask, social distance and vaccinate as many people, we may come out of this pandemic in 6 months' time.' 'If we decide to be disciplined, we can get out of this pandemic in the next 6 months.' 'If not, it is any body's guess.'

Can Wastewater Testing tell us more about COVID-19?

Can Wastewater Testing tell us more about COVID-19?

Rediff.com6 Jul 2020

'Wastewater containing excreted material can tell us how a community is doing in a particular area pertaining to any epidemic, pandemic, and other bacterial and viral diseases.'

Abhijit's Nobel and the challenges ahead

Abhijit's Nobel and the challenges ahead

Rediff.com4 Nov 2019

'The fruition of Nobel's hope lies in the response of a caring government that can rise above politics and propaganda, not in the frenetic raptures of a public that worships fame for fame's sake,' says Sunanda K Datta-Ray.

COVID-19: 'Maharashtra is putting up a fight'

COVID-19: 'Maharashtra is putting up a fight'

Rediff.com23 Mar 2021

'But to see the effects of that, it will take a week or two more.'

'Both vaccines will be similar in immunity'

'Both vaccines will be similar in immunity'

Rediff.com11 Jan 2021

'Whenever you roll out: effectiveness is important, operational logistics are important, side effects are important and vaccine hesitancy is important.'

The healthy and young may not even ever receive The Vaccine

The healthy and young may not even ever receive The Vaccine

Rediff.com4 Jan 2021

'What proportion of the people require the vaccine for us to manage this entire COVID-19 situation?'

How tech alumni plan to raise 21,000 crore to fight COVID-19

How tech alumni plan to raise 21,000 crore to fight COVID-19

Rediff.com2 Jul 2020

Over 5 million alumni from the Indian Institutes of Technology, Mumbai University and Institute of Chemical Technology, Mumbai, plan to raise Rs 21,000 crore to start the world's largest infection testing lab in Mumbai.

In battle against COVID-19, India faces new challenges

In battle against COVID-19, India faces new challenges

Rediff.com29 May 2020

The pandemic is set to become even more challenging, with migrant workers returning home, relaxations in lockdown rules, and the approaching monsoon. However, states are looking at community participation to ramp up testing and home treatment of patients

Exploring a cheap sanitiser to fight coronavirus

Exploring a cheap sanitiser to fight coronavirus

Rediff.com10 Apr 2020

'If it works, something good can come out of this tragedy for the common public good,' say Dr Prasad Gadgil and Dr Kunal Basu.

Coronavirus: What about the Lab in Wuhan?

Coronavirus: What about the Lab in Wuhan?

Rediff.com12 Apr 2020

Why did the Chinese military take over the lab in Wuhan in end January? Did something go wrong? Claude Arpi glances at the mystery surrounding the origin of the coronavirus.

How much coffee is just right for you?

How much coffee is just right for you?

Rediff.com24 Sep 2018

Caffeine, the drug that gives coffee its kick, works differently, depending on the consumer's weight, gender, hormonal shifts and a variety of other factors.

'More younger people are dying in India than in US'

'More younger people are dying in India than in US'

Rediff.com4 May 2020

'If you look at the age group of people who died in India, the average age is 35!' 'That's why as a country we should be much more concerned.'

Curiosity rover finds evidence of ingredients for life on Mars: NASA

Curiosity rover finds evidence of ingredients for life on Mars: NASA

Rediff.com25 Mar 2015

Curiosity has detected traces of nitrogen on Mars surface, adding evidence that the red planet could have once supported life.

What CMs told PM Modi during video meet on COVID-19

What CMs told PM Modi during video meet on COVID-19

Rediff.com12 May 2020

While some CMs suggested reopening economic activity in phases, others pitched for the extension of the coronavirus lockdown, but with a carefully crafted exit strategy